Cargando…
Elucidating the Impact of Bacterial Lipases, Human Serum Albumin, and FASII Inhibition on the Utilization of Exogenous Fatty Acids by Staphylococcus aureus
Staphylococcus aureus only synthesizes straight-chain or branched-chain saturated fatty acids (SCFAs or BCFAs) via the type II fatty acid synthesis (FASII) pathway, but as a highly adaptive pathogen, S. aureus can also utilize host-derived exogenous fatty acids (eFAs), including SCFAs and unsaturate...
Autores principales: | Pruitt, Emily L., Zhang, Rutan, Ross, Dylan H., Ashford, Nathaniel K., Chen, Xi, Alonzo, Francis, Bush, Matthew F., Werth, Brian J., Xu, Libin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327171/ https://www.ncbi.nlm.nih.gov/pubmed/37425828 http://dx.doi.org/10.1101/2023.06.29.547085 |
Ejemplares similares
-
Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials
por: Morvan, Claire, et al.
Publicado: (2016) -
Synergy Between Beta-Lactams and Lipo-, Glyco-, and Lipoglycopeptides, Is Independent of the Seesaw Effect in Methicillin-Resistant Staphylococcus aureus
por: Zhang, Rutan, et al.
Publicado: (2021) -
Varied Contribution of Phospholipid Shedding From Membrane to Daptomycin Tolerance in Staphylococcus aureus
por: Shen, Tianwei, et al.
Publicado: (2021) -
(p)ppGpp/GTP and Malonyl-CoA Modulate Staphylococcus aureus Adaptation to FASII Antibiotics and Provide a Basis for Synergistic Bi-Therapy
por: Pathania, Amit, et al.
Publicado: (2021) -
Staphylococcus aureus secreted lipases do not inhibit innate immune killing mechanisms
por: Sargison, Fiona, et al.
Publicado: (2021)